Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and

Binh An Diep1, Liana Chan, Pierre Tattevin

  • 1Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, CA 94110, USA. bdiep@medsfgh.ucsf.edu

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes severe necrotizing pneumonia. Panton-Valentine leukocidin (PVL) produced by USA300 strains significantly increases virulence and mortality in a rabbit model.

Area of Science:

  • Microbiology
  • Pathogenesis
  • Toxicology

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a significant public health threat.
  • Panton-Valentine leukocidin (PVL) is a key virulence factor in CA-MRSA, implicated in necrotizing pneumonia.
  • Existing rodent models have limitations in studying PVL's role due to differences in polymorphonuclear leukocyte (PMN) susceptibility.

Purpose of the Study:

  • To investigate the role of PVL in CA-MRSA USA300 pathogenesis using a rabbit model.
  • To compare the virulence of PVL-producing and PVL-deficient USA300 strains.
  • To elucidate the mechanism of PVL-induced lung injury.

Main Methods:

  • Development of a rabbit model for necrotizing pneumonia.
  • Comparison of USA300 wild-type, PVL-deletion mutant, and complemented strains.
  • Administration of purified PVL directly into rabbit lungs.

Main Results:

  • PVL significantly enhanced USA300 virulence, causing severe lung necrosis, edema, hemorrhage, and death.
  • Purified PVL induced lung inflammation and injury by recruiting and lysing PMNs.
  • Rabbit PMNs, similar to human PMNs, are susceptible to PVL-induced cytolysis, validating the model.

Conclusions:

  • PVL is a critical determinant of severe necrotizing pneumonia caused by CA-MRSA USA300.
  • The rabbit model is suitable for studying PVL-mediated pathogenesis and lung injury.
  • Understanding PVL's mechanism provides insights into fatal pneumonia treatment strategies.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inflammation01:38

Inflammation

Overview